Categories
AFNewsNG Logo
Health Special Report

New COVID-19 Vaccine Trial Shows Promising Result

Thompson Nsisongabasi

May 19, 2020

The WebMD website on Monday has said 45 participants have received a new vaccine trial for COVID-19.

READ ALSO: Jim Iyke Sparks Outrage: "Doctors Are Trained Not to Heal - Sickness Is Their BusinessÔÇØ

The vaccine which was produced by Moderna, a Massachusetts-based company was given to 45 participants, and all of them developed detectable antibodies.

READ ALSO: See Lebanese man who put Nigerian woman up for sale on Facebook arrested

The vaccine called mRNA-1273 is in three different dosage levels of 25, 100 and 250 micrograms.

READ ALSO: Abia: How Policemen Allegedly Killed Young Man In Umuahia Over Land | SEE PHOTOS

The company further revealed that eight people who received doses of 25 and 100 micrograms in March responded best, developing antibodies that were just as high or higher than the antibodies found in people who had gotten the coronavirus and then recovered.

READ ALSO: Abia: APC disowns Apugo over comment against 2019 guber aspirants

The company added it plans to move ahead with the next two phases, in which larger numbers of people will be tested this year.

READ ALSO: REVEALED: How Common House Rats Can Kill - Shocking Truth Behind Silent Deaths in Nigerian Homes

The vaccine uses something called the messenger RNA approach.

READ ALSO: How a Nigerian Professor's AI System Could Predict Depression Before Symptoms Emerge

"I think the totality of science tells us that this is the right antigen and it should be protective,ÔÇØ Tal Zaks, Moderna's chief medical officer said.

READ ALSO: ABIA 2023: Engr Nwafor Gets Rousing Welcome From Ngwaukwu, Isiala Ngwa North | PHOTOS

The testing is being done in coordination with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases.

Related Stories

""

— Thompson Nsisongabasi

Join the Conversation

Signed in as Member